TY - JOUR
T1 - Experimental evidence of oxidative stress in patients with L-2-hydroxyglutaric aciduria and that L-carnitine attenuates in vitro DNA damage caused by D-2-hydroxyglutaric and L-2-hydroxyglutaric acids
AU - Rodrigues, Daiane Grigolo Bardemaker
AU - de Moura Coelho, Daniella
AU - Sitta, Ângela
AU - Jacques, Carlos Eduardo Diaz
AU - Hauschild, Tatiane
AU - Manfredini, Vanusa
AU - Bakkali, Abdellatif
AU - Struys, Eduard A.
AU - Jakobs, Cornelis
AU - Wajner, Moacir
AU - Vargas, Carmen Regla
PY - 2017/8/1
Y1 - 2017/8/1
N2 - D-2-hydroxyglutaric (D-2-HGA) and L-2-hydroxyglutaric (L-2-HGA) acidurias are rare neurometabolic disorders biochemically characterized by increased levels of D-2-hydroxyglutaric acid (D-2-HG) and L-2-hydroxyglutaric acid (L-2-HG) respectively, in biological fluids and tissues. These diseases are caused by mutations in the specific enzymes involved in the metabolic pathways of these organic acids. In the present work, we first investigated whether D-2-HG and L-2-HGA could provoke DNA oxidative damage in blood leukocytes and whether L-carnitine (LC) could prevent the in vitro DNA damage induced by these organic acids. It was verified that 50 μM of D-2-HG and 30 μM of L-2-HG significantly induced DNA damage that was prevented by 30 and 150 μM of LC. We also evaluated oxidative stress parameters in urine of L-2-HGA patients and observed a significant increase of oxidized guanine species and di-tyrosine, biomarkers of oxidative DNA and protein damage, respectively. In contrast, no significant changes of urinary isoprostanes and reactive nitrogen species levels were observed in these patients. Taken together, our data indicate the involvement of oxidative damage, especially on DNA, in patients affected by these diseases and the protective effect of LC.
AB - D-2-hydroxyglutaric (D-2-HGA) and L-2-hydroxyglutaric (L-2-HGA) acidurias are rare neurometabolic disorders biochemically characterized by increased levels of D-2-hydroxyglutaric acid (D-2-HG) and L-2-hydroxyglutaric acid (L-2-HG) respectively, in biological fluids and tissues. These diseases are caused by mutations in the specific enzymes involved in the metabolic pathways of these organic acids. In the present work, we first investigated whether D-2-HG and L-2-HGA could provoke DNA oxidative damage in blood leukocytes and whether L-carnitine (LC) could prevent the in vitro DNA damage induced by these organic acids. It was verified that 50 μM of D-2-HG and 30 μM of L-2-HG significantly induced DNA damage that was prevented by 30 and 150 μM of LC. We also evaluated oxidative stress parameters in urine of L-2-HGA patients and observed a significant increase of oxidized guanine species and di-tyrosine, biomarkers of oxidative DNA and protein damage, respectively. In contrast, no significant changes of urinary isoprostanes and reactive nitrogen species levels were observed in these patients. Taken together, our data indicate the involvement of oxidative damage, especially on DNA, in patients affected by these diseases and the protective effect of LC.
KW - D-2-hydroxyglutaric aciduria
KW - DNA damage
KW - L-2-hydroxyglutaric aciduria
KW - L-carnitine
KW - Oxidative stress
UR - http://www.scopus.com/inward/record.url?scp=85017413625&partnerID=8YFLogxK
U2 - 10.1016/j.tiv.2017.04.006
DO - 10.1016/j.tiv.2017.04.006
M3 - Article
C2 - 28396261
AN - SCOPUS:85017413625
SN - 0887-2333
VL - 42
SP - 47
EP - 53
JO - Toxicology in Vitro
JF - Toxicology in Vitro
ER -